Achilles Therapeutics Plc - ADR

NASDAQ:ACHL   3:59:15 PM EDT
0.77
-0.01 (-1.20%)
7:27:35 PM EDT: $0.77 -0.01 (-1.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Achilles Therapeutics Plc - ADR Stock, NASDAQ:ACHL

245 Hammersmith Road, London, Greater London W6 8PW
United Kingdom
Phone: +44.20.8154.4600
Number of Employees: 215
http://www.achillestx.com

Description

Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.